Navigation Links
Stents Slightly Better Than Bypass for Blocked Left Coronary Artery
Date:1/29/2008

But experts question results of small Polish study

TUESDAY, Jan. 29 (HealthDay News) -- Implanting a stent in a clogged left main coronary artery appeared to give better short-term results than bypass surgery in a Polish study.

But American experts cast some doubt on the clinical value of the finding.

The study, led by cardiologists at the Medical University of Silesia, compared results of surgery versus stenting in 105 patients with serious blockages of the left main coronary artery, which is vital for heart function, because it feeds three other vessels.

There was a significant increase in the heart's blood-pumping ability over the next 12 months in the 52 participants who got the stent implants, but not in the 53 who underwent bypass surgery, said a report in the Feb. 5 issue of the Journal of the American College of Cardiology.

The incidence of major adverse events and the rate of survival was lower in the 30 days following the procedure for stent recipients than for patients who had surgery, the report said, "with a trend toward improved survival" in a two-year follow-up after stent implant.

"One of the limitations of this study is the very small number of patients," said Dr. Edward L. Hannan, assistant dean for research at the State University of New York at Albany, who recently reported at a meeting that surgery tended to be better than stenting for people with blockage of more than one heart artery.

And looking closely at the results, Hannan said he found "no significant difference" between the two methods in the incidence of major adverse events in the longer follow-up.

The Polish results differ from those of one he has done, which he is about to submit to a medical journal for publication, Hannan said. That study, which was not a controlled trial but looked at results reported in clinical practice, found an advantage for surgery over stenting.

But the report has yet to pass the peer review required by medical journals, he cautioned. "No one should trust the results until it has passed peer review," Hannan said.

The surgery-versus-stent question is important for the left main coronary artery, because it is not a blood vessel readily amenable to surgery, Hannan explained. Nevertheless, his research found that surgery "is used much more frequently than angioplasty in current practice, at least 10 times more often. So, we had only a small group of angioplasty patients in our study," he said.

Dr. Howard C. Herrmann, the director of the Interventional Cardiology and Cardiac Catheterization Laboratories at the University of Pennsylvania who has done studies on the subject, found a number of weaknesses in the Polish research, including the small number of patients.

One notable weakness is the relatively short follow-up period, Herrmann explained.

"Their survival time is out to about two years," he said. "Something as important as left main disease might not manifest itself for five years."

Accordingly, older studies that established surgery as the recommended treatment for the condition measured survival at five years or longer, Herrmann noted. "The bottom line from my standpoint is that this study shows that left main stenting is feasible," he said. "I don't think it answers the question about whether it is a better strategy than surgery, which is still considered the standard therapy."

Another report in the same issue of the journal questioned the growing use of a valved stent for aortic stenosis, a condition in which narrowing of a valve reduces the flow of blood from the heart to the aorta and onward to the rest of the body.

The study, by French cardiologists, of 35 cases in which a valved stent was implanted for severe aortic stenosis, found consistent misplacement of the device. "Premature failure of implanted valve stents... might be an important concern in the future," the report warned.

More information

You can learn more about why and how stents are used from the American Heart Association.



SOURCES: Edward L. Hannan, M.D., assistant dean, research, State University of New York at Albany; Howard C. Herrmann, M.D., director, Interventional Cardiology and Cardiac Catheterization Laboratories, and professor, medicine, University of Pennsylvania, Philadelphia; Feb. 5, 2008, Journal of the American College of Cardiology


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Nanowire coating for bone implants, stents
2. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
3. Drug-Coated Stents Go Head to Head
4. Study Finds Benefits With Drug-Coated Stents
5. New Canadian study finds drug coated heart stents to be safe:
6. Aeon Bioscience Continues Development of Drug Eluting Stents
7. Drug-Coated Stents No Riskier in Long Run Than Bare Metal Ones
8. Top10 research advances include studies on genetics and stem cell research, stents
9. Study looks at off-label use of biliary stents
10. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
11. Surgery Better Than Stents for Multiple Blockages
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stents Slightly Better Than Bypass for Blocked Left Coronary Artery
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: